Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Therapies for HER2+ Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04836156
What this trial is testing

Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for Human Epidermal Growth Factor Receptor 2 (HER2) Negative Early Breast Cancer Patients

Who this might be right for
HER2-negative Early Breast Cancer
Peking University People's Hospital 46
Testing effectiveness (Phase 2)Looking for participantsNCT04750122
What this trial is testing

Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients

Who this might be right for
HER2-positive Early Breast Cancer
Peking University People's Hospital 46
Testing effectiveness (Phase 2)Looking for participantsNCT06498154
What this trial is testing

Eliminating Breast Surgery for Breast Cancer Patients With Clinical Complete Response to Neoadjuvant Systemic Therapy

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 200
Early research (Phase 1)Study completedNCT04081389
What this trial is testing

Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8+16 more
Roswell Park Cancer Institute 9
Post-approval studies (Phase 4)Not Yet RecruitingNCT06868017
What this trial is testing

Randomized Controlled Clinical Study of Efficacy and Safety of Initumab Combined with Pyrrotinib and Chemotherapeutic Agents in Neoadjuvant Therapy for HER2-positive Breast Cancer with Different Treatment Cycles

Who this might be right for
HER2 Positive Breast Cancer
The First Hospital of Jilin University 208
Testing effectiveness (Phase 2)Looking for participantsNCT06964906
What this trial is testing

Neoadjuvant High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab and Chemotherapy for ER-Positive /HER2-Negative Breast Cancer

Who this might be right for
ER+/HER2- Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 30
Not applicableEnded earlyNCT02963363
What this trial is testing

Adapted Physical Activity for Breast Cancer HER2 Positive Patient

Who this might be right for
HER2 Positive Breast Cancer
Centre Jean Perrin 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT02876107
What this trial is testing

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

Who this might be right for
Breast CarcinomaBreast LumpEdema+8 more
M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Study completedNCT01196052
What this trial is testing

Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 153
Large-scale testing (Phase 3)Looking for participantsNCT04547907
What this trial is testing

A Comparison of Nab-PHP and TCbHP Efficacy in Neoadjuvant Therapy for HER2-positive Early Breast Cancer

Who this might be right for
Breast Cancer,HER2-positive
Henan Cancer Hospital 688
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07189884
What this trial is testing

Pyrotinib Maleate Tablets in Combination With Dalpiciclib Isethionate Tablets and Standard Endocrine Therapy

Who this might be right for
Locally Advanced Breast Cancer (LABC)
The First Affiliated Hospital of Xiamen University 33
Large-scale testing (Phase 3)Study completedNCT01583426
What this trial is testing

Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)

Who this might be right for
Tubular Breast Cancer Stage IIMucinous Breast Cancer Stage IIBreast Cancer Female NOS+5 more
GBG Forschungs GmbH 1,229
Testing effectiveness (Phase 2)Active Not RecruitingNCT03982485
What this trial is testing

Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast Cancer

Who this might be right for
Breast Cancer
RenJi Hospital 196
Testing effectiveness (Phase 2)Study completedNCT00450892
What this trial is testing

Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 129
Testing effectiveness (Phase 2)Study completedNCT00841828
What this trial is testing

Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ Patients

Who this might be right for
Breast Cancer
Spanish Breast Cancer Research Group 102
Large-scale testing (Phase 3)UnknownNCT03507465
What this trial is testing

Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
Guangdong Provincial People's Hospital 290
Not applicableNot Yet RecruitingNCT07019272
What this trial is testing

Neratinib in Extended Adjuvant Treatment for HER2+ Early Breast Cancer With pCR But High-Risk Features: A Hebei Multi-Center Real-World Study

Who this might be right for
HER2-positive Breast Cancer
Hebei Medical University Fourth Hospital 170
Early research (Phase 1)Looking for participantsNCT04144023
What this trial is testing

A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

Who this might be right for
Breast Ductal Carcinoma In Situ
Mayo Clinic 43
Testing effectiveness (Phase 2)Study completedNCT00943410
What this trial is testing

Trastuzumab and External Beam Radiation Therapy in Treating Women With Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT05638594
What this trial is testing

Pyrotinib Combined With Trastuzumab, Dalpiciclib, Letrozole Versus TCbHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast Cancer

Who this might be right for
Breast Cancer
Shengjing Hospital 236
Next Page